Claudia Gulea
Overview
Explore the profile of Claudia Gulea including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
92
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gini R, Pajouheshnia R, Gardarsdottir H, Bennett D, Li L, Gulea C, et al.
Pharmacoepidemiol Drug Saf
. 2024 May;
33(5):e5787.
PMID: 38724471
Purpose: Real-world evidence (RWE) is increasingly used for medical regulatory decisions, yet concerns persist regarding its reproducibility and hence validity. This study addresses reproducibility challenges associated with diversity across real-world...
2.
Gulea C, Zakeri R, Kallis C, Quint J
BMJ Open
. 2022 Jun;
12(6):e059122.
PMID: 35772828
Objective: To evaluate the association between having concomitant chronic obstructive pulmonary disease (COPD) or asthma, and in-patient mortality and post-discharge management among patients hospitalised for acute heart failure (HF). Setting:...
3.
Whittaker H, Gulea C, Koteci A, Kallis C, Morgan A, Iwundu C, et al.
BMJ
. 2021 Dec;
375:e065834.
PMID: 34965929
Objectives: To describe the rates for consulting a general practitioner (GP) for sequelae after acute covid-19 in patients admitted to hospital with covid-19 and those managed in the community, and...
4.
Gulea C, Zakeri R, Quint J
Ann Am Thorac Soc
. 2021 Dec;
19(6):971-980.
PMID: 34905461
Differences in clinical presentation and outcomes between heart failure (HF) phenotypes in patients with chronic obstructive pulmonary disease (COPD) have not been assessed. The aim of this study was to...
5.
Gulea C, Quint J, Zakeri R
Eur Heart J
. 2021 May;
42(34):3407-3408.
PMID: 33948644
No abstract available.
6.
Gulea C, Zakeri R, Alderman V, Morgan A, Ross J, Quint J
Respir Res
. 2021 Feb;
22(1):64.
PMID: 33622362
Background: Beta-blockers are associated with reduced mortality in patients with cardiovascular disease but are often under prescribed in those with concomitant COPD, due to concerns regarding respiratory side-effects. We investigated...
7.
Gulea C, Zakeri R, Quint J
BMC Med
. 2021 Jan;
19(1):9.
PMID: 33455580
Background: Comorbidities affect outcomes in heart failure (HF), but are not reflected in current HF classification. The aim of this study is to characterize HF groups that account for higher-order...
8.
Betts M, Rane P, Bergrath E, Chitnis M, Bhutani M, Gulea C, et al.
Health Qual Life Outcomes
. 2020 Jul;
18(1):251.
PMID: 32718355
Objective: Identify the most recent utility value estimates for cardiovascular disease (CVD) via systematic literature review (SLR) and explore trends in utility elicitation methods in the last 6 years. Methods:...
9.
10.
Gulea C, Zakeri R, Quint J
Int J Cardiol
. 2019 May;
290:113-118.
PMID: 31101544
Background: Patients hospitalized for heart failure (HF) are at high risk of readmission. Chronic obstructive pulmonary disease (COPD) is one of the most prevalent comorbidities in this population. However, few...